The future begins now.
At its 165th meeting in Strasbourg on November 26/27, 2019, the European Pharmacopoeia Commission decided to include a new general chapter "Test for bacterial endotoxins using recombinant factor C" in the current edition of the European Pharmacopoeia. This is the culmination of the long development and implementation in the market of a replacement for the endotoxin sensor factor C (recombinant factor C = rFC), which is normally extracted from the horseshoe crab.
It is now time for new technologies to replace old paradigms.
If you want to know what possibilities rFC-based endotoxin testing offers to you, then you have the opportunity to hear a presentation on the subject directly from Brendan Tindall, our Global solutions Manager EndoNext, in Salzburg on March 24, 2020.
In addition, you will have the opportunity to experience our solutions in a live product demonstration and to receive insights into the practical validation of recombinant Factor C as an endotoxin test method from Sophia Pfeifer of Boehringer Ingelheim Biberach.
Of course, we will answer all your questions and there will also be the opportunity to exchange ideas with colleagues in a relaxed atmosphere.